Search research articles
Contact Us
Filters
Showing results (311-320 of 349) with videos related to
Page
of 35
Sort By:
Pediatric Blood & Cancer
|
October 15, 2013
Successful treatment of an infant with CDA type II by intrauterine transfusions and postnatal stem cell transplantation
M Braun, M Wölfl, V Wiegering, et al.
Bone Marrow Transplantation
|
July 1, 1989
Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approaches
R Arnold, C R Bartram, B Heinze, et al.
Onkologie
|
June 1, 1979
[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study]
M Dietrich, C Abt, R Arnold, et al.
Haematologica
|
May 9, 2000
Geographic distribution of CDA-II: did a founder effect operate in Southern Italy?
A Iolascon, V Servedio, R Carbone, et al.
Blut
|
October 1, 1985
Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood products
V Erfle, R Hehlmann, W Mellert, et al.
Blood
|
July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
The New England Journal of Medicine
|
May 9, 1991
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group
N Frickhofen, J P Kaltwasser, H Schrezenmeier, et al.
Annals of Hematology
|
March 1, 1993
Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial results
A Ganser, G Heil, K Kolbe, et al.
Annals of Hematology
|
August 1, 1993
Interferon in chronic myeloid leukemia. A workshop report
M Griesshammer, R Hehlmann, A Hochhaus, et al.
Journal of Interferon Research
|
August 1, 1994
Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia
P Von Wussow, R Hehlmann, T Hochhaus, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 349) with videos related to
Sort By:
Page
of 35
Pediatric Blood & Cancer
|
October 15, 2013
Successful treatment of an infant with CDA type II by intrauterine transfusions and postnatal stem cell transplantation
M Braun, M Wölfl, V Wiegering, et al.
Bone Marrow Transplantation
|
July 1, 1989
Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approaches
R Arnold, C R Bartram, B Heinze, et al.
Onkologie
|
June 1, 1979
[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study]
M Dietrich, C Abt, R Arnold, et al.
Haematologica
|
May 9, 2000
Geographic distribution of CDA-II: did a founder effect operate in Southern Italy?
A Iolascon, V Servedio, R Carbone, et al.
Blut
|
October 1, 1985
Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood products
V Erfle, R Hehlmann, W Mellert, et al.
Blood
|
July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
The New England Journal of Medicine
|
May 9, 1991
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group
N Frickhofen, J P Kaltwasser, H Schrezenmeier, et al.
Annals of Hematology
|
March 1, 1993
Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial results
A Ganser, G Heil, K Kolbe, et al.
Annals of Hematology
|
August 1, 1993
Interferon in chronic myeloid leukemia. A workshop report
M Griesshammer, R Hehlmann, A Hochhaus, et al.
Journal of Interferon Research
|
August 1, 1994
Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia
P Von Wussow, R Hehlmann, T Hochhaus, et al.
Page
of 35